Neoadjuvant Treatment with Weekly High-Dose 5-Fluorouracil as 24-Hour Infusion, Folinic Acid and Oxaliplatin in Patients with Primary Resectable Liver Metastases of Colorectal Cancer

Axel Wein,C. Riedel,W. Brückl,Susanne Merkel,R. Ott,Bert Hanke,Ulrich Baum,Florian S. Fuchs,Klaus Günther,T. Reck,T. Papadopoulos,Eckhart G. Hahn,W. Hohenberger

Neoadjuvant Treatment with Weekly High-Dose 5-Fluorouracil as 24-Hour Infusion, Folinic Acid and Oxaliplatin in Patients with Primary Resectable Liver Metastases of Colorectal Cancer

2003

Axel Wein
C. Riedel
W. Brückl
Susanne Merkel
R. Ott
Bert Hanke
Ulrich Baum
Florian S. Fuchs
Klaus Günther
T. Reck
T. Papadopoulos
Eckhart G. Hahn
W. Hohenberger

Purpose: To evaluate the efficacy and safety of neoadjuvant treatment comprising weekly high-dose 5-fluorouracil (5-FU) as a 24-hour infusion, folinic acid (FA) and biweekly oxalipl

Keywords:

Pathology
Immunology
Neoadjuvant therapy
Phases of clinical research
Colorectal cancer
Fluorouracil
Antimetabolite
Oxaliplatin
Medicine
Folinic acid
Chemotherapy
Metastasis
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations